Home » Tenders » Europe » Germany » Openhouse Method - Div. Active Ingredients from 01.10, 2020 Tender, Germany - 64123371

Openhouse Method - Div. Active Ingredients from 01.10, 2020 Tender, Germany - 64123371

Download Documents

AOK RHEINLAND / HAMBURG - THE HEALTH INSURANCE has floated a tender for Openhouse Method - Div. Active Ingredients from 01.10, 2020. The project location is Germany and the tender is closing on 15 Aug 2022. The tender notice number is 122113-2022, while the TOT Ref Number is 64123371. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Openhouse Method - Div. Active Ingredients from 01.10, 2020

Deadline : 15 Aug 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 64123371

Document Ref. No. : 122113-2022

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK RHEINLAND / HAMBURG - THE HEALTH INSURANCE
Address: Kasernenstr. 61
Town: Dusseldorf
Nuts Code: DE - Germany
Postal Code: 40213
CONTACT POINT: Division of medicines / pharmacies
Germany
Email :open-house@rh.aok.de
URL :www.aok.de/rh

Tender Details

Document Type: Corrigendum / Additional Information (Please refer to Document)

Title: Openhouse procedure - Div. Active ingredients from 01.10.2020

Reference Number: 2020 - Business Area Arize / Pharmacies

Contract Type: Supplies

DESCRIPTION: Discounting non-exclusive discount agreements pursuant to Section 130a (8) SGB V with at any time at a time of the context of so-called "Openhouse method" for various drug active ingredients with the earliest possible contract start on 01.10.2020.

.

The concrete pharmaceutical agents and the respective contract launches can be found in the current medicinal product list in the project space of the DTVP procurement portal in the "Assignment Document" section.

.

On 01.10.2020 contracts for the following active ingredients are offered:

.

Abacavir

Abacavir / Dolutegravir / Lamivudin

Abacavir / Lamivudin / Zidovudin

Abatacept

Acetylcystein rx

Acetylcystein non-rx

Acetylsalicylic acid exclusively according to Appendix 1 AM-RL G-BA Regulatory Products

Acitretin

Adalimumab

Agomelatin

Alitetion in

Ambrisentan

Amphotericin B

Anagrelide except N3 packs of Dar HKP with ...